细胞外心肌容积在主动脉瓣狭窄患者中的预后价值
结果显示ECV%与左室失代偿标志物相关,且独立预测全因死亡(每增加1%的HR为1.10)。
要点
- 严重主动脉瓣狭窄患者中,ECV%升高与左室质量、左房容积、NYHA III/IV级、晚期钆增强及较低左室射血分数相关。
- ECV%是全因死亡的独立预测因子,校正年龄、性别、射血分数和晚期钆增强后,每增加1%的HR为1.10。
- ECV%在不同扫描仪制造商、磁场强度或T1 mapping序列间无显著差异。
核心结论
- 在计划接受主动脉瓣干预的严重主动脉瓣狭窄患者中,ECV%升高是左室失代偿的标志,并且是全因死亡的强独立预测因子。
主要发现
- ECV%与左室质量、左房容积、NYHA III/IV级、晚期钆增强及较低左室射血分数相关(所有p<0.05),其中与晚期钆增强和左室射血分数的关联独立于其他临床变量(p=0.035和p<0.001)。
- 中位随访3.8年,52例死亡,其中14例为心血管原因;ECV%三分位组间全因死亡率逐渐增加(17.3、31.6、52.7例死亡/1000患者年;log-rank p=0.009)。
- ECV%与心血管死亡相关(p=0.003),且校正年龄、性别、射血分数和晚期钆增强后仍独立与全因死亡相关(每增加1%的HR=1.10;95%CI 1.02-1.19;p=0.013)。
临床怎么用
- 对于严重主动脉瓣狭窄拟行瓣膜干预的患者,可考虑通过心脏磁共振测量ECV%来评估左室失代偿和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myocardial fibrosis is a key mechanism of left ventricular decompensation in aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) measures such as extracellular volume fraction (ECV%). Outcomes following aortic valve intervention may be linked to the presence and extent of myocardial fibrosis. OBJECTIVES: This study sought to determine associations between ECV% and markers of left ventricular decompensation and post-intervention clinical outcomes. METHODS: Patients with severe aortic stenosis underwent CMR, including ECV% quantification using modified Look-Locker inversion recovery-based T1 mapping and late gadolinium enhancement before aortic valve intervention. A central core laboratory quantified CMR parameters. RESULTS: Four-hundred forty patients (age 70 ± 10 years, 59% male) from 10 international centers underwent CMR a median of 15 days (IQR: 4 to 58 days) before aortic valve intervention. ECV% did not vary by scanner manufacturer, magnetic field strength, or T1 mapping sequence (all p > 0.20). ECV% correlated with markers of left ventricular decompensation including left ventricular mass, left atrial volume, New York Heart Association functional class III/IV, late gadolinium enhancement, and lower left ventricular ejection fraction (p < 0.05 for all), the latter 2 associations being independent of all other clinical variables (p = 0.035 and p < 0.001). After a median of 3.8 years (IQR: 2.8 to 4.6 years) of follow-up, 52 patients had died, 14 from adjudicated cardiovascular causes. A progressive increase in all-cause mortality was seen across tertiles of ECV% (17.3, 31.6, and 52.7 deaths per 1,000 patient-years; log-rank test; p = 0.009). Not only was ECV% associated with cardiovascular mortality (p = 0.003), but it was also independently associated with all-cause mortality following adjustment for age, sex, ejection fraction, and late gadolinium enhancement (hazard ratio per percent increase in ECV%: 1.10; 95% confidence interval [1.02 to 1.19]; p = 0.013). CONCLUSIONS: In patients with severe aortic stenosis scheduled for aortic valve intervention, an increased ECV% is a measure of left ventricular decompensation and a powerful independent predictor of mortality.
引用
- Everett RJ, Treibel TA, Fukui M, et al. Extracellular Myocardial Volume in Patients With Aortic Stenosis. J Am Coll Cardiol. 2020. PMID: 31976869. doi:10.1016/j.jacc.2019.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。